Oncolytics Biotech (ONCY) Return on Assets [ROA] (2009 - 2026)
Oncolytics Biotech (ONCY) recorded Return on Assets [ROA] of -382.07% in Q2 2026, down 226.83 percentage points from -155.25% a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Oncolytics Biotech reported Return on Assets [ROA] of -273.86%, down 165.51 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -190.80 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -108.34% in FY2024 (-36.48 pp), -71.86% in FY2023 (-14.03 pp), -57.84% in FY2022 (+9.63 pp) and -67.47% in FY2021 (+15.59 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q4 2010.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 12.98 percentage points in Q4 2021, against a drop of 226.83 percentage points in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.14% |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - | -382.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -382.07% |
| Sep 30, 2025 | -198.40% |
| Jun 30, 2025 | -154.03% |
| Mar 31, 2025 | -161.61% |
| Dec 31, 2024 | -142.72% |
| Sep 30, 2024 | -98.23% |
| Jun 30, 2024 | -84.21% |
| Mar 31, 2024 | -75.86% |
| Dec 31, 2023 | -64.90% |
| Sep 30, 2023 | -82.26% |
| Jun 30, 2023 | -79.43% |
| Mar 31, 2023 | -73.72% |
| Dec 31, 2022 | -75.31% |
| Sep 30, 2022 | -62.34% |
| Jun 30, 2022 | -63.23% |
| Dec 31, 2021 | -54.25% |
| Sep 30, 2021 | -50.83% |
| Jun 30, 2021 | -52.59% |
| Mar 31, 2021 | -63.72% |
| Dec 31, 2020 | -57.15% |
API Access
Oncolytics Biotech Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();